Stockanalysis: A Detailed Look for Value-Focused Investors
Stockanalysis is a financial data website that provides free access to income statements, balance sheets, cash flow statements, and basic valuation ratios for thousands of U.S. and international equities. The site draws millions of monthly visitors because it loads fast, organizes data clearly, and covers most stocks that retail investors ask about. For value-focused investors, the real question is whether stockanalysis goes deep enough to support buy and sell decisions rooted in fundamentals, or whether it is a starting point that requires supplementing with more specialized tools.
This post works through the platform's data depth, its actual utility for value investing, and the specific gaps that matter when you are trying to assess quality businesses at fair prices.
Key Takeaways
- Stockanalysis provides clean, free access to 10 years of financial statements and standard valuation ratios for most listed equities.
- The platform lacks composite quality scores, normalized earnings tools, and proprietary scoring that separates a good business from a cheap one.
- Value investors who rely solely on stockanalysis for decisions tend to miss critical signals around capital efficiency, earnings quality, and balance sheet integrity.
- EV/EBITDA and price-to-book are available on the site but are presented without historical context or industry-relative benchmarks.
- The Altman Z-Score, a key bankruptcy risk signal, is not calculated or displayed on stockanalysis.
- Combining stockanalysis data with a composite scoring framework like the VMCI Score gives a more complete analytical picture.
What Stockanalysis Actually Covers
The core of the platform is financial statement data. You can pull 10 years of annual and quarterly income statements, balance sheets, and cash flow statements for any major U.S. ticker in seconds. The formatting is table-based, downloadable as CSV, and refreshed promptly after earnings releases.
Beyond statements, stockanalysis shows a standard set of valuation ratios: P/E, price-to-sales, price-to-free-cash-flow, EV/EBITDA, and price-to-book. These are displayed at the current price, not as trailing 5-year ranges, which limits their usefulness for mean-reversion analysis.
The site also covers ETFs, IPOs, and some international markets. For U.S.-listed companies, the data is generally accurate and updated within a day of earnings releases.
Where Stockanalysis Falls Short for Value Investors
Stockanalysis is built for data access, not analytical judgment. That distinction matters when you are running a value investing process. Here are the four gaps that come up most often.
No quality scoring. The site shows ROE and ROIC for many companies but does not aggregate these into a quality signal. Apple (AAPL) has an ROIC near 45.1%, which is exceptional. Microsoft (MSFT) runs near 35%. Most companies cannot generate returns above their cost of capital. Stockanalysis gives you the raw numbers but does not rank them, flag outliers, or compare them to industry peers automatically.
No earnings normalization. Reported earnings are frequently distorted by one-time charges, tax adjustments, and restructuring costs. Stockanalysis shows GAAP net income. For companies like Berkshire Hathaway (BRK.B), where unrealized investment gains flow through the income statement, reported earnings are nearly meaningless in any given quarter. You need normalized or adjusted earnings to form a reliable valuation view, and stockanalysis does not provide them.
No bankruptcy risk signal. The Altman Z-Score is one of the few quantitative tools with a solid track record of predicting financial distress. A score below 1.8 signals high bankruptcy risk. Stockanalysis does not calculate or display it.
No price-to-intrinsic-value framework. A P/E ratio tells you what the market is paying today. A DCF tells you what the business is worth over the next decade. Stockanalysis does not include a DCF tool or any intrinsic value estimate.
How the Standard Metrics Display Compares to What You Need
| Metric | Available on Stockanalysis | What Value Analysis Requires |
|---|---|---|
| P/E Ratio | Yes, current only | Current + 5-year range + sector median |
| EV/EBITDA | Yes, current only | Current + normalized + historical |
| Price-to-Book | Yes | Current + decomposed by asset quality |
| ROIC | Partial (some tickers) | Consistent, 5-year trend |
| Altman Z-Score | No | Calculated from balance sheet inputs |
| Piotroski F-Score | No | 9-point integrity check on financials |
| DCF / Intrinsic Value | No | 4-model DCF with sensitivity analysis |
| Composite Quality Score | No | Weighted across value, quality, integrity |
This table is not meant to argue that stockanalysis is a poor product. It is a strong data source. The gap is that data without analytical structure requires the investor to do the analytical heavy lifting manually, and most investors do not have a consistent framework for doing that.
Using Stockanalysis as Part of a Research Process
The most productive way to use stockanalysis is as the raw data layer underneath a more structured analytical process. Pull the financial statements to verify numbers. Use the 10-year history to spot trends in margins, revenue growth, and capital expenditure. Cross-reference the P/E and EV/EBITDA against your own valuation range.
Then move to a platform that gives you composite scoring. Our screener runs 120 indicators across five VMCI pillars: Value (35%), Quality (30%), Integrity (15%), Growth (12%), and Risk (8%). The difference between a stock scoring 72 on that framework and a stock scoring 44 is specific and explainable, not a gut call.
Johnson & Johnson (JNJ) scores well on Quality and Integrity because of its 3.1% dividend yield, 30+ consecutive years of dividend growth, and a Piotroski F-Score of 8. None of those signals are visible in aggregate on stockanalysis. You have to know to look for them individually and then synthesize them yourself.
Stockanalysis for Income and Dividend Investors
The dividend data on stockanalysis is useful at a surface level. You can see current yield, annual payout, and dividend history going back several years. Coca-Cola (KO), for example, shows a current yield near 3.0% and a decades-long payment streak.
What the site does not show is dividend safety metrics: payout ratio relative to free cash flow, dividend coverage ratio, or how the yield compares to the stock's own 5-year and 10-year history. A dividend investor needs those signals to distinguish a sustainable payout from one that is about to be cut. Those calculations exist in our screener and in the glossary definitions for each metric at ValueMarkers.
Stockanalysis for Growth Stock Analysis
Growth investors use stockanalysis differently from value investors. The primary use case is monitoring revenue growth rates, gross margin trends, and free cash flow conversion quarter by quarter. For that specific task, the platform is quite capable. The quarterly segment is well-organized and the YoY comparison is automatic.
The issue for growth investors is the same as for value investors: the data is raw. A revenue growth rate of 22% is either wonderful or mediocre depending on the sector, the competitive environment, and the path to profitability. Stockanalysis shows the number. It does not contextualize it.
What the Altman Z-Score Adds That Stockanalysis Skips
The Altman Z-Score is calculated from five balance sheet and income statement ratios: working capital to total assets, retained earnings to total assets, EBIT to total assets, market cap to total liabilities, and revenue to total assets. A score above 2.99 signals financial health. Between 1.8 and 2.99 is a grey zone. Below 1.8 is distress territory.
Stockanalysis gives you all the inputs needed to calculate this score manually. But most investors do not do that calculation manually for every company they screen. A tool that surfaces it automatically is materially faster and less error-prone.
We include the Altman Z-Score in the ValueMarkers glossary with a worked example, so you can understand the formula before relying on any platform's pre-calculated output.
How Stockanalysis Handles International Stocks
For U.S.-listed equities, stockanalysis is comprehensive and accurate. For international equities, the coverage thins considerably. European, Asian, and Canadian markets are represented, but the historical depth is often shorter, some derived ratios are absent, and the update lag after non-U.S. earnings releases can be longer.
Value investors who focus on international markets typically find that stockanalysis works well as a cross-reference source but not as their primary research tool for non-U.S. names. For global fundamental data with consistent coverage, institutional platforms or regional data providers fill the gap more reliably.
This geographic limitation matters when you are evaluating multinational businesses. Nestlé, Toyota, or LVMH may appear on the platform, but the depth of 10-year financial history available for each will generally be less than what you get for Apple or Microsoft.
Using Stockanalysis in a Backtesting Context
Quantitative investors who backtest value strategies face a specific challenge with stockanalysis: the platform does not provide point-in-time data. It shows historical financial statements, but those statements reflect as-reported figures, not the figures that were publicly known on any given historical date.
This creates a look-ahead bias problem. If you use the 2019 annual report data to simulate a screening decision made in January 2019, the platform may show restated figures that were not available until a later filing amendment. True point-in-time backtesting requires a vendor that preserves data vintages at the time of original filing.
For investors who want to backtest qualitatively without strict point-in-time discipline, the historical statements on stockanalysis are a reasonable starting point. For rigorous quantitative backtesting, Compustat or a similar institutional feed is necessary.
Reading the Cash Flow Statement on Stockanalysis
The cash flow statement is the most analytically powerful of the three financial statements, and it is also the most frequently misread. Stockanalysis presents it clearly, which makes it a good place to develop this skill.
Key signals to read from the cash flow statement on stockanalysis:
Operating cash flow versus net income. These should grow at roughly similar rates over time. When operating cash flow consistently exceeds net income, accounting quality is high. When net income exceeds operating cash flow for multiple consecutive years, something in the accruals is inflating reported earnings.
Capital expenditure trend. A business that is investing heavily in growth shows rising capex relative to revenue. A business in harvest mode shows declining capex. Neither is inherently good or bad, but the trend changes the interpretation of free cash flow.
Share repurchases. Stockanalysis shows buybacks in the financing activities section. A company that generates $5 billion in free cash flow and returns $4 billion via buybacks is allocating capital efficiently. A company that borrows to fund buybacks is a different situation entirely, and the cash flow statement reveals that distinction clearly.
Dividend consistency. For dividend investors, the financing activities section shows cash paid for dividends each year. Cross-referencing this against operating cash flow gives you a simple dividend coverage ratio that is more conservative and more accurate than the earnings-based payout ratio.
The VMCI Score as the Analytical Layer Stockanalysis Lacks
The VMCI Score is ValueMarkers' composite quality framework, applied to over 3,000 equities through our screener. It weights five pillars: Value (35%), Quality (30%), Integrity (15%), Growth (12%), and Risk (8%).
Each pillar aggregates multiple indicators. The Value pillar incorporates P/E, EV/EBITDA, price-to-book, free cash flow yield, and their historical context. The Quality pillar measures ROIC, ROE, gross margin consistency, and capital efficiency over time. The Integrity pillar includes the Piotroski F-Score, Altman Z-Score, and accruals ratio.
A stock scoring 70 or above on the VMCI framework is, by the metrics we track, a high-quality business trading at a reasonable price. A stock scoring below 40 has material weaknesses in at least one or two pillars that warrant caution.
Stockanalysis gives you the raw inputs for the Value and partial inputs for the Quality pillars. The Integrity pillar, the Growth pillar, and the Risk pillar require additional calculation that the platform does not perform. That is the gap the VMCI Score fills.
Further reading: SEC Investor.gov · FINRA
Why stock analysis tools Matters
This section anchors the discussion on stock analysis tools. The detailed treatment, formula, and worked examples appear in the body of this article above. The points below summarize the most important takeaways for value investors who want to apply stock analysis tools in real portfolio decisions. ValueMarkers exposes the underlying data on every covered ticker via the screener and stock profile pages, so the concepts in this article translate directly into actionable filters.
Key inputs for stock analysis tools
See the main discussion of stock analysis tools in the sections above for the full treatment, including the inputs, the calculation methodology, the typical sector benchmarks, and the most common pitfalls to avoid. The ValueMarkers screener lets value investors filter the full universe of 100,000+ stocks across 73 exchanges using stock analysis tools alongside the rest of the 120-indicator composite, with sector percentiles and historical trends shown on every stock profile.
Sector benchmarks for stock analysis tools
See the main discussion of stock analysis tools in the sections above for the full treatment, including the inputs, the calculation methodology, the typical sector benchmarks, and the most common pitfalls to avoid. The ValueMarkers screener lets value investors filter the full universe of 100,000+ stocks across 73 exchanges using stock analysis tools alongside the rest of the 120-indicator composite, with sector percentiles and historical trends shown on every stock profile.
Related ValueMarkers Resources
- Enterprise Value to EBITDA (EV/EBITDA) — Enterprise Value to EBITDA is the metric used to how cheaply a stock trades relative to its fundamentals
- Altman Z-Score — Altman Z-Score is the metric used to the reliability of reported earnings versus underlying cash flow
- Pb Ratio — Glossary entry for Pb Ratio
- Stock Analysiscom — related ValueMarkers analysis
- Stockanalysis Com — related ValueMarkers analysis
- Russell 1000 Index Vs Sp 500 — related ValueMarkers analysis
Frequently Asked Questions
What is stockanalysis?
Stockanalysis is a free financial data website that aggregates income statements, balance sheets, cash flow statements, and standard valuation ratios for equities listed on major U.S. exchanges and several international markets. It is most commonly used by retail investors and students who need quick access to a company's historical financials without paying for a Bloomberg or FactSet subscription.
How do you calculate stockanalysis?
Stockanalysis is a website, not a calculation. The underlying financial metrics it displays, such as EV/EBITDA, price-to-book, or ROIC, each follow their own formulas. EV/EBITDA equals enterprise value divided by earnings before interest, taxes, depreciation, and amortization. Price-to-book equals the current share price divided by book value per share. The site pulls these from reported financial statements and applies standard formulas.
Why is stockanalysis important for investors?
Stockanalysis reduces the time it takes to access 10 years of a company's financial history from hours of manual SEC filing work to seconds. That time saving is real and meaningful, particularly during initial screening when you are evaluating a large number of candidates. The limitation is that data access is not the same as analytical judgment, and the platform provides the former without much of the latter.
How to use stockanalysis in stock analysis?
Start with the financial statements tab to review 10 years of revenue, operating income, net income, and free cash flow trends. Look for consistency and growth. Then move to the ratios section to check current P/E, EV/EBITDA, and price-to-book against your own valuation benchmarks. Use the data as raw material, then run the same company through a composite scoring tool to assess quality and risk signals that the site does not surface automatically.
What is a good stockanalysis for value stocks?
For value stocks, a useful stockanalysis process focuses on: P/E below the stock's own 5-year average, EV/EBITDA in the bottom third of its sector, price-to-book below 1.5 (for asset-heavy businesses), ROIC consistently above 10%, and free cash flow yield above 5%. A stock like BRK.B at a price-to-book near 1.5 historically represents fair value by Graham-style metrics. Stockanalysis gives you the raw ratios; you supply the threshold judgment.
What are the limitations of stockanalysis?
The main limitations are: no composite quality or integrity scoring, no Altman Z-Score or Piotroski F-Score, no normalized earnings adjustments, no DCF or intrinsic value calculator, no historical valuation ranges, and no industry-relative benchmarking built into the display. These are not minor omissions for serious fundamental analysis. They represent the difference between a data library and an analytical platform.
Use our comparison tool to see how ValueMarkers stacks up against stockanalysis and other financial data sites across the specific metrics that matter for fundamental investing.
Written by Javier Sanz, Founder of ValueMarkers. Last updated April 2026.
Ready to find your next value investment?
ValueMarkers tracks 120+ fundamental indicators across 100,000+ stocks on 73 global exchanges. Run the methodology above in seconds with our stock screener, or see today's top-ranked names on the leaderboard.
Related tools: DCF Calculator · Methodology · Compare ValueMarkers
Disclaimer: This content is for informational and educational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any security. Past performance does not guarantee future results. Consult a licensed financial advisor before making investment decisions.